A40 基础学科综合 标准查询与下载

ISO/IEC 19794-6:2005 信息技术.生物测量数据交换格式.第6部分:虹膜图像数据

This part of ISO/IEC 19794 specifies two alternative image interchange formats for biometric authentication systems that utilize iris recognition. The first is based on a rectilinear image storage format that may be a raw, uncompressed array of intensity values or a compressed format such as that specified by ISO/IEC 15444. The second format is based on a polar image specification that requires certain pre-processing and image segmentation steps, but produces a much more compact data structure that contains only iris information. Data that comply with either one of the iris image formats specified in this part of ISO/IEC 19794 are intended to be embedded in a CBEFF-compliant structure in the CBEFF Biometric Data Block (BDB) as specified in ISO/IEC 19785-1.

Information technology - Biometric data interchange formats - Part 6: Iris image data

KS B 7070-2005 宏观参数交换标准.概述

이 규격은 매크로 파라메트릭 교환 표준 규격의 개요에 대하여 규정한다.

Macro-parametric data exchange－Overview

ANSI/INCITS 409.3-2005 信息技术.生物统计特性试验和报告.第3部分:方案测试和报告

This standard specifies the requirements for scenario-based biometric testing and reporting. The goal of scenario testing is to determine the overall system performance in a prototype or simulated application. Testing is carried out on a complete system in an environment that models a real-world target application of interest. Each tested system will have its own acquisition sensor and so will receive slightly different data. Consequently, care will be required that data collection across all tested systems is in the same environment with the same population. Test results will be repeatable only to the extent that the modeled scenario can be carefully controlled.

Information technology - Biometric Performance Testing and Reporting - Part 3: Scenario Testing and Reporting

ANSI/INCITS 409.2-2005 信息技术.生物统计特性试验和报告.第2部分:技术试验和报告

This standard specifies methods for performance testing of biometric systems and devices. It constitutes a specialization of a biometric testing framework standard in that it is concerned only with the offline use of stored (i.e. previously captured) biometric samples, and not the interaction of human subjects with a biometric sensor.

Information technology - Biometric Performance Testing and Reporting - Part 2: Technology Testing and Reporting

ANSI/INCITS 409.1-2005 信息技术.生物统计特性试验和报告.第1部分:原则和框架

This standard addresses testing the accuracy of identification and verification devices, algorithms, and systems. This standard does NOT address related performance issues such as throughput, turnaround-time, cost of ownership, life-time cycle costs, user implementations, environmental impact, cost/benefit breakpoints, etc. This part is intended to summarize the other parts of the standard. An overview of the primary testing protocols, biometric applications, and performance metrics is presented. It also provides guidance on data analysis techniques, recording of results, and performance reporting measures available.

Information technology - Biometric Performance Testing and Reporting - Part 1: Principles and Framework

ARMY MIL-HDBK-46855 A VALID NOTICE 1-2004 人体工程学项目过程和程序

MIL-HDBK-46855A, dated 17 May 1999, has been reviewed and determined to be valid for use in acquisition

HUMAN ENGINEERING PROGRAM PROCESS AND PROCEDURES

ASTM E2360-04 孟氏隐唇瓢虫Mulsant规范

1.1 This specification covers information on and the test method for determining purity, sex ratio, and number of adults in shipments of the predatory beetle Cryptolaemus montrouzieri.

Specification for Cryptolaemus montrouzieri Mulsant (Coleoptera: Coccinellidae)

ASTM E2368-04 应变控制热力疲劳试验的标准规程

1.1 This practice covers the determination of thermomechanical fatigue (TMF) properties of materials under uniaxially loaded strain-controlled conditions. A "thermomechanical" fatigue cycle is here defined as a condition where uniform temperature and strain fields over the specimen gage section are simultaneously varied and independently controlled. This practice is intended to address TMF testing performed in support of such activities as materials research and development, mechanical design, process and quality control, product performance, and failure analysis. While this practice is specific to strain-controlled testing, many sections will provide useful information for force-controlled or stress-controlled TMF testing.1.2 This practice allows for any maximum and minimum values of temperature and mechanical strain, and temperature-mechanical strain phasing, with the restriction being that such parameters remain cyclically constant throughout the duration of the test. No restrictions are placed on environmental factors such as pressure, humidity, environmental medium, and others, provided that they are controlled throughout the test, do not cause loss of or change in specimen dimensions in time, and are detailed in the data report.1.3 The use of this practice is limited to specimens and does not cover testing of full-scale components, structures, or consumer products.

Standard Practice for Strain Controlled Thermomechanical Fatigue Testing

ASTM D7026-04 通过碳同位素分析测定材料的生物基含量的测定结果的抽样和报告用标准指南

1.1 This guide provides a framework for collecting and handling samples for determination of biobased content of materials by means of the carbon isotope method described in Test Methods D 6866. Tests for sampling adequacy based on the standard statistical tools are provided. In addition, reporting of the results, including sampling techniques and handling procedures and chain-of-custody issues are discussed.1.2 This guide is concerned with collecting representative samples within a given material or a lot, not with lot-to-lot variations such as considered in quality control schemes.1.3 Biobased materials often represent sampling problems specific to a given material, such as heterogeneity, and so forth, which require employment of material-specific sampling methods. The use of specialized sampling methods already accepted and validated by industries that manufacture and/or use the biomaterial is encouraged. However, all sampling techniques, especially non-standard techniques developed for specific materials must be reported in sufficient detail to allow critical assessment of the techniques used.1.4 Carbon isotope analysis involves thermal processing in presence of oxidants. Compatibility of any given material with Test Methods D 6866 must be assessed. Special attention must be given to materials with potential for explosion hazards, such as peroxides, nitrated compounds, azides, and so forth. Examples of peroxide-forming compounds are ethers, some ketones and a number of other compounds.1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use.Note 18212;There is no similar or equivalent ISO standard.

Standard Guide for Sampling and Reporting of Results for Determination of Biobased Content of Materials via Carbon Isotope Analysis

ASTM E1873-04 用多聚酶链式反应技术对核酸序列的测定的标准指南

1.1 This guide covers guidelines, recommendations, basic considerations, criteria, and principles to be employed when developing, utilizing, or assessing PCR procedures and specific protocols for the amplification and detection of nucleic acid sequences. This guide is not intended to be a standard procedure with a list of requirements for PCR detection of nucleic acids. This guide is intended to provide information that will assist the user in obtaining quality and reliable data.1.2 Nucleic acid sequences that can be amplified by PCR include DNA, as well as RNA sequences; RNA sequences are suitable targets for PCR following reverse transcription of the RNA to complementary DNA (cDNA). This type of amplification technique is often called reverse transcription-PCR (RT-PCR).1.3 This guide has been developed for use in any molecular biology/biotechnology laboratory. This includes, but is not limited to, laboratories that specialize in the diagnosis of human, animal, plant, or bacterial diseases.1.4 This guide conveys the general procedural terminology of PCR technology used for the detection of nucleic acids.1.5 This guide is a general one; it does not cover the additional guidance that would be needed for specific applications, for example, for the PCR detection of nucleic acid sequences of specific microorganisms.1.6 This guide does not cover details of the various methods that can be utilized to identify PCR-amplified DNA sequences.1.7 This guide does not cover specific variations of the basic PCR or RT-PCR technology (for example, quantitative PCR, real-time PCR, multiplex PCR, and in situ PCR), and it does not cover details of instrument calibration.1.8 Warning8212;Laboratory work involving certain clinical specimens and microorganisms can be hazardous to personnel. Warning8212;Biosafety level 2 (or higher) facilities are recommended for biohazard work (8). Safety guidelines should be adhered to in accordance with NCCLS M29-A2 and other recommendations (8).

Standard Guide for Detection of Nucleic Acid Sequences by the Polymerase Chain Reaction Technique

ASTM E1853M-04 用指示器基因测试系统测定感应CYP1A的共面有机化合物的存在的标准指南

The compounds that bind to the Ah-receptor and induce CYP1A have often been shown to be either more toxic or carcinogenic, or both, than other organic compounds. Dioxins, furans, and PCBs have been shown to bioconcentrate in exposed organisms and biomagnify in the food web (see Guide E 1023). Testing with birds, mammals, and fish species has shown that exposure to these compounds can produce physiological, reproductive and histopathological effects (12, 13). Concern for the possible contamination of water, food, wildlife, soil, and aquatic sediment from these compounds has led to the requirement for analytical chemical analyses of a great many environmental samples. Use of a screening tool such as this Human Reporter Gene System (HRGS) will allow identification of significantly contaminated samples. These methods will aid in the cost-effective separation of high priority samples from those that do not require further costly chemical characterization.1.1 This guide covers the recommended guidelines for performing a test for presence of organic compounds that bind to the Ah Receptor and induce the CYP1A locus on the vertebrate chromosome. Under appropriate test conditions, induction of CYP1A is evidence that the cells have been exposed to one or more of these xenobiotic organic compounds that include dioxins, furans, coplanar PCBs, and several polycyclic aromatic hydrocarbons (PAHs). Detection of induction has been made simple and rapid by the stable integration of the firefly plasmid such that Ah-receptor binding results in the production of luciferase. Luciferase production is a function of both the potency of the compound(s) and the concentration. This type of Human Reporter Gene System (HRGS) has shown concentration-response relationships using 2,3,7,8-TCDD, 5 coplanar PCBs, and several polycyclic aromatic hydrocarbons (PAHs) (1-3). This guide describes test conditions under which solvent extracts of environmental samples (water, tissue, soil, or sediments) may be tested for the presence of CYP1A-inducing organic compounds.1.2 The test procedures presented in this guide have been published previously (4, 5 ) and established as EPA Method 4425 (6). These references should be consulted to obtain details regarding the construction and maintenance of the cell line, and the response of the cells to various organic substances.1.3 All laboratory health and safety procedures should be followed. This includes the use of glasses, gloves, and other protective clothing, when handling the reagents. Information on toxicity, handling procedures and waste procedures should be reviewed prior to use of all chemicals.1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

Standard Guide for Measuring the Presence of Planar Organic Compounds Which Induce CYP1A, Using Reporter Gene Test Systems

ASTM E2360-04(2010) 孟氏隐唇瓢虫 瓢虫( 鞘翅目:瓢虫科)

The efficacy of mealybug control by C. montrouzieri depends on accurate release numbers of beetles, presence of male and female beetles, and absence of live product contaminants. Accurate packaging and maintenance of purity and viability of C. montrouzieri shipments is, therefore, essential for the effective management of the target pest. This test method is intended for use by producers and end-users of the specified biological control agent. It is complementary to the quality guidelines for Cryptolaemus montrouzieri . 1.1 This specification covers information on and the test method for determining purity, sex ratio, and number of adults in shipments of the predatory beetle Cryptolaemus montrouzieri. 1.2 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

Specification for Cryptolaemus montrouzieri Mulsant (Coleoptera: Coccinellidae)

DB42/T 274-2003 蓝藻及其制品中微囊藻毒素的检测方法

本标准规定了蓝藻及其制品中微囊藻毒素的检测方法。本标准适用于蓝藻及其制品中微囊藻毒素的检测。

Analysis of microcystins in cyanobacteria and its products

DB42/T 276-2003 藻蓝蛋白粉

本标准夫定了藻蓝蛋白粉的要求、试验方法、检验规则、标志、包装、运输和贮存。本标准适用于以蓝藻为原料，经超滤等步骤提取、加工制成的藻蓝蛋白粉。主要用于食品、化妆品、医药等行业的原料。

Phycocyanin Powder

DB42/T 275-2003 水体中微囊藻毒素的检测方法

本标准规定了水体中微囊藻毒素的检测方法。本标准适用于水体中微囊藻毒素的检测。

The method for determination of microcystins in water body

NY/T 703-2003 红花花绒

Safflower

NY/T 702-2003 啤酒花

Hop

ISO/IEC TR 19760:2003 系统工程.ISO/IEC 15288(系统寿命过程)的应用指南

1 Purpose This Technical Report provides guidance for the application of ISO/IEC 15288 Systems engineering — System life cycle processes (referred to as the International Standard) to systems and projects of various size and type. This Technical Report can be used as a companion document to the International Standard. This Technical Report elaborates on factors that should be considered when applying the International Standard. It does this in the context of the various illustrative ways in which the International Standard may be applied. Also, lists within this Technical Report are not meant to be exhaustive but to provide the user with examples to consider. The guidance contained in this Technical Report may be tailored as appropriate to the system and project using guidance in Annex A of the International Standard and 4.4 of this Technical Report. This Technical Report is intended to provide appropriate links to other ISO documents for supporting application of the International Standard and to aid in assessing the effectiveness of the application of the International Standard. Not all areas of the International Standard are meant to have equal treatment in this Technical Report. More specific information is provided where providing such information will help in the application of the International Standard. This Technical Report is not meant to provide how-to guidance for each area of the International Standard. 2 Audience This Technical Report is applicable to audiences such as identified below: a) those who apply the International Standard; b) those who use the International Standard for a specific system; c) those who prepare organizational and specific domain standards based on the International Standard. 3 Prerequisites The list below provides prerequisites for users of this Technical Report: a) availability of ISO/IEC 15288; b) familiarity with ISO/IEC 15288; c) familiarity with relevant organizational and project policies; d) general knowledge of project management, systems engineering and system life cycle models.

Systems engineering - A guide for the application of ISO/IEC 15288 (System life cycle processes)

ARMY MIL-STD-1472 F CHG NOTICE 1-2003 人体工程学

This standard has been approved for use by all Departments and Agencies of the Department of Defense.

HUMAN ENGINEERING

ASTM F2315-03 藻酸胶中活细胞或组织的固定或包围的标准指南

The main use is to immobilize, support, or suspend living cells or tissue in a matrix. The use of an encapsulation/immobilization system may protect cells or tissues from immune rejection. When immobilizing biological material in alginate gels, there are numerous parameters that must be controlled. This guide contains a list of these parameters and describes the methods and types of testing necessary to properly characterize, assess, and ensure consistency in the performance of an encapsulation system using alginate. This guide only covers single gelled beads, coated or not, and not double capsules or other constructs. The alginate gelation technology covered by this guide may allow the formulation of cells and tissues into biomedical devices for use as tissue engineered medical products or drug delivery devices. These products may be appropriate for implantation based on supporting biocompatibility and physical test data. Recommendations in this guide should not be interpreted as a guarantee of clinical success in any tissue engineered medical product or drug delivery application.DESIG: F2315 03 ^TITLE: Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels ^SCOPE:1. Scope 1.1 This guide discusses information relevant to the immobilization or encapsulation of living cells or tissue in alginate gels. Immobilized or encapsulated cells are suitable for use in biomedical and pharmaceutical applications, or both, including, but not limited to, Tissue Engineered Medical Products (TEMPs).1.2 This guide addresses key parameters relevant for successful immobilization and encapsulation in alginate gels.This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use.

Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels